AMY DENTON: Open Payments
NPI 1457026775 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 25 payments from 11 companies in 2025. Trend: 2023 $204 · 2024 $383 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $182 |
| ABBVIE INC. | 4 | $99 |
| Ardelyx, Inc. | 3 | $74 |
| Gilead Sciences, Inc. | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Ferring Pharmaceuticals Inc. | 2 | $49 |
| Aimmune Therapeutics, Inc. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| Celltrion USA Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
Products named: REZDIFFRA, IBSRELA, DUPIXENT, RINVOQ, REBYOTA, VOQUEZNA, VEGZELMA, VOWST.
Industry payments across FL — which companies pay providers there.
